MuseCell Innovations Enters U.S. Market, Bringing Restorative Stem Cell Therapy Directly to American PatientsMuseCell Innovations (MCI), the exclusive global licensor of Dezawa MuseCells®, today announced its U.S. launch. By making this restorative therapy available domestically, MCI eliminates the need for overseas patient travel, democratizing access to authentic Dezawa MuseCell® therapy through licensed providers in Florida, Utah, Tennessee and Georgia, with additional states to likely follow.
